+Search query
-Structure paper
Title | Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes. |
---|---|
Journal, issue, pages | Bioorg. Med. Chem. Lett., Vol. 19, Page 2468-2473, Year 2009 |
Publish date | Feb 12, 2009 (structure data deposition date) |
Authors | Benardeau, A. / Benz, J. / Binggeli, A. / Blum, D. / Boehringer, M. / Grether, U. / Hilpert, H. / Kuhn, B. / Marki, H.P. / Meyer, M. ...Benardeau, A. / Benz, J. / Binggeli, A. / Blum, D. / Boehringer, M. / Grether, U. / Hilpert, H. / Kuhn, B. / Marki, H.P. / Meyer, M. / Puntener, K. / Raab, S. / Ruf, A. / Schlatter, D. / Mohr, P. |
External links | Bioorg. Med. Chem. Lett. / PubMed:19349176 |
Methods | X-ray diffraction |
Resolution | 2.2 - 2.3 Å |
Structure data | PDB-3g8i: PDB-3g9e: |
Chemicals | ChemComp-RO7: ChemComp-HOH: |
Source |
|
Keywords | TRANSCRIPTION/TRANSFERASE / NUCLEAR HORMONE RECEPTOR / TRANSCRIPTION FACTOR / DIABETES / Activator / DNA-binding / Metal-binding / Nucleus / Polymorphism / Receptor / Transcription / Transcription regulation / Zinc / Zinc-finger / Acyltransferase / Alternative splicing / Chromosomal rearrangement / Phosphoprotein / Proto-oncogene / Transferase / Ubl conjugation / TRANSCRIPTION-TRANSFERASE COMPLEX / NUCLEAR RECEPTOR / Diabetes mellitus / Disease mutation / Obesity |